Skip to main content
. 2018 Oct 4;19(10):3030. doi: 10.3390/ijms19103030

Figure 6.

Figure 6

Sonographic representation of IP-tumor growth and response to antibody-bound drug loaded nanomicelle hydrogel composite delivery system (AF(D)NMs). (a) Ascitic fluid development in a nude mouse 5 days post-induction; (b) Tumor growth 10 days post induction with NIH:OVAR-5 cell suspension; (c) Chemotherapeutic implant injected IP-adjacent to tumor growth 11 days post-induction, (d) decrease in tumor size and only a small tumor nodule was noticeable 15 days after implementation of the IP-(AF(D)NMs) treatment.